To evaluate the safety and efficacy of percutaneous CT-guided radiofrequency ablation (RFA) for small renal masses (SRMs) at a large single-institution center during a period of 12 years.
A total of 118 patients underwent RFA for SRM between July 2006 and July 2018 at our institution.